U.S.-headquartered CRO Crown Bioscience’s San Diego laboratory has received Clinical Laboratory Improvement Amendments (CLIA) certification. This milestone enables Crown Bioscience to deliver clinical-grade testing, strengthening its support for clients’ clinical and translational drug development efforts. CLIA, regulated by the Centers for Medicare and Medicaid Services (CMS), sets rigorous federal standards for accuracy, reliability, and quality laboratory operations. With this design...